A carregar...
Molecular imaging with positron emission tomography and computed tomography (PET/CT) for selecting first-line targeted treatment in metastatic breast cancer: a cost-effectiveness study
Our aim was to evaluate the potential cost-effectiveness of PET/CT with FES and (89)Zr-trastuzumab compared to pathology to select first-line targeted treatment in metastatic breast cancer (MBC) patients with non-rapidly progressive disease. A previously published and validated model was extended an...
Na minha lista:
| Publicado no: | Oncotarget |
|---|---|
| Main Authors: | , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Impact Journals LLC
2018
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5929430/ https://ncbi.nlm.nih.gov/pubmed/29731987 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.24869 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|